Target engagement imaging of PARP inhibitors in small-cell lung cancer

Treatment of small-cell lung cancer remains a challenge due to multiple mechanisms of resistance to current therapies; measuring patient response is crucial in adapting and choosing adequate treatment. Here the authors develop a strategy to visualise in vivo dynamics of a class of widely used PARP i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brandon Carney, Susanne Kossatz, Benjamin H. Lok, Valentina Schneeberger, Kishore K. Gangangari, Naga Vara Kishore Pillarsetty, Wolfgang A. Weber, Charles M. Rudin, John T. Poirier, Thomas Reiner
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/e625a8f0d4ae4e3f93d027d2afb43df5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e625a8f0d4ae4e3f93d027d2afb43df5
record_format dspace
spelling oai:doaj.org-article:e625a8f0d4ae4e3f93d027d2afb43df52021-12-02T16:49:50ZTarget engagement imaging of PARP inhibitors in small-cell lung cancer10.1038/s41467-017-02096-w2041-1723https://doaj.org/article/e625a8f0d4ae4e3f93d027d2afb43df52018-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-02096-whttps://doaj.org/toc/2041-1723Treatment of small-cell lung cancer remains a challenge due to multiple mechanisms of resistance to current therapies; measuring patient response is crucial in adapting and choosing adequate treatment. Here the authors develop a strategy to visualise in vivo dynamics of a class of widely used PARP inhibitors.Brandon CarneySusanne KossatzBenjamin H. LokValentina SchneebergerKishore K. GangangariNaga Vara Kishore PillarsettyWolfgang A. WeberCharles M. RudinJohn T. PoirierThomas ReinerNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Brandon Carney
Susanne Kossatz
Benjamin H. Lok
Valentina Schneeberger
Kishore K. Gangangari
Naga Vara Kishore Pillarsetty
Wolfgang A. Weber
Charles M. Rudin
John T. Poirier
Thomas Reiner
Target engagement imaging of PARP inhibitors in small-cell lung cancer
description Treatment of small-cell lung cancer remains a challenge due to multiple mechanisms of resistance to current therapies; measuring patient response is crucial in adapting and choosing adequate treatment. Here the authors develop a strategy to visualise in vivo dynamics of a class of widely used PARP inhibitors.
format article
author Brandon Carney
Susanne Kossatz
Benjamin H. Lok
Valentina Schneeberger
Kishore K. Gangangari
Naga Vara Kishore Pillarsetty
Wolfgang A. Weber
Charles M. Rudin
John T. Poirier
Thomas Reiner
author_facet Brandon Carney
Susanne Kossatz
Benjamin H. Lok
Valentina Schneeberger
Kishore K. Gangangari
Naga Vara Kishore Pillarsetty
Wolfgang A. Weber
Charles M. Rudin
John T. Poirier
Thomas Reiner
author_sort Brandon Carney
title Target engagement imaging of PARP inhibitors in small-cell lung cancer
title_short Target engagement imaging of PARP inhibitors in small-cell lung cancer
title_full Target engagement imaging of PARP inhibitors in small-cell lung cancer
title_fullStr Target engagement imaging of PARP inhibitors in small-cell lung cancer
title_full_unstemmed Target engagement imaging of PARP inhibitors in small-cell lung cancer
title_sort target engagement imaging of parp inhibitors in small-cell lung cancer
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/e625a8f0d4ae4e3f93d027d2afb43df5
work_keys_str_mv AT brandoncarney targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT susannekossatz targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT benjaminhlok targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT valentinaschneeberger targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT kishorekgangangari targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT nagavarakishorepillarsetty targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT wolfgangaweber targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT charlesmrudin targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT johntpoirier targetengagementimagingofparpinhibitorsinsmallcelllungcancer
AT thomasreiner targetengagementimagingofparpinhibitorsinsmallcelllungcancer
_version_ 1718383248000679936